Table 3.

Age-standardized Prevalence in 2018

Age, years	Observed migraine patients	Expected migraine patients	Observed prevalence, %	Expected prevalence, %
18–19	128	2067.06	1.09%	17.58%
20–24	1438	9063.77	3.05%	19.24%
25–29	2949	9190.36	6.51%	20.29%
30–34	3950	9253.19	9.02%	21.14%
35–39	4140	8923.05	9.93%	21.41%
40–44	3369	7564.33	9.60%	21.56%
45–49	2779	5063.06	11.02%	20.07%
50–54	2555	3966.67	11.74%	18.23%
55–59	2503	3680.37	11.15%	16.39%
60–64	2272	3124.92	10.24%	14.08%
65–69	1638	2296.70	8.37%	11.74%
70–74	1072	1440.39	7.05%	9.47%
75–79	582	830.59	5.56%	7.93%
80–84	333	626.92	3.66%	6.89%
85–89	163	369.97	2.68%	6.08%
90–94	44	187.80	1.17%	5.00%
≥ 95	23	407.41	0.21%	3.70%
Total	29,938	68,056.53	7.65%	17.38%